SHS stands for life science and medical technology investments.

For more than 25 years.

Our investment focus

From growth to medium-sized companies: We invest in fast-growing companies in the life science and medical technology sector.

Our portfolio

From cardiology to digital health: Our portfolio currently comprises more than 20 companies from the various life science and medical technology sub sectors.

Our investors

From pension funds to family offices: For many years partners have entrusted us with their capital in order to achieve attractive returns on it.

We invest in European healthcare champions

SHS

Experience for more
than 25 years

Since its foundation in 1993, SHS has been investing in innovative companies in the life science and medical technology sectors.

With our investments, we help shape European champions in their respective healthcare segments or support them in their further expansion.

In addition to capital, we essentially provide our networks and expertise in the areas of approval and reimbursement in the USA and China, marketing/sales, staffing and exit.

SHS in figures

28

Years of history

5

Fund generations

55

Transactions

130

Million €
current fund volume

215

Million €
AUM
(ca.)

500

Transactions assessments p.a.
(ca.)

Latest News

13 September 2021 - Press Releases

Medtech-INSIDE – Part 11: “Wearables, Apps & Co: Digital tools of a new medicine”

12 August 2021 - Press Releases

Medtech-INSIDE – Part 10: “Indispensable: Security in a digitalized medicine”

5 August 2021 - Newsletter

New in the portfolio: SHS participates in globally growing surgical platform Incision